Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Leukemia

  Free Subscription


24.08.2026

1 Ann Hematol
1 Biochem Pharmacol
2 Blood
1 Bone Marrow Transplant
2 Cancer
1 Int J Hematol
3 Leuk Lymphoma
3 Leukemia
1 Oncogene


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Hematol

  1. GARCIA-SANTISTEBAN R, Kaufman M, Vinay M, Chung HJ, et al
    Myeloid sarcoma of the septum pellucidum causing hallucinations and personality changes in an elderly woman: a case report.
    Ann Hematol. 2026;105:380.
    PubMed         Abstract available


    Biochem Pharmacol

  2. KIM H, Diederich M
    Gut microbiome crosstalk in acute myeloid leukemia: mechanisms, treatment-associated dysbiosis, and translational opportunities.
    Biochem Pharmacol. 2026;253.
    PubMed         Abstract available


    Blood

  3. MARZUTTINI F, Potenza A, Celli L, Simioni A, et al
    T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradication.
    Blood. 2026;148:995-1010.
    PubMed         Abstract available

  4. BENDIG S, Hartmann AM, Wessels W, Beder T, et al
    IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.
    Blood. 2026;148:1026-1032.
    PubMed         Abstract available


    Bone Marrow Transplant

  5. NEVEN Q, Berbis J, Michel G, Domenech C, et al
    Long-term complications after total body irradiation in children younger than 4 years transplanted for acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2026 Aug 20. doi: 10.1038/s41409-026-03014.
    PubMed         Abstract available


    Cancer

  6. VALTIS YK, Frost BF, Nemirovsky D, Derkach A, et al
    Blinatumomab administration in the outpatient setting: Safety and health care utilization.
    Cancer. 2026;132:e70566.
    PubMed         Abstract available

  7. BONO R, Rotolo C, Sapienza G, Spoto C, et al
    In vivo T-cell depletion and pharmacokinetic-based busulfan conditioning regimen improve the outcomes in acute myeloid leukemia (AML) in complete remission undergoing to allogeneic stem cell transplantation.
    Cancer. 2026;132:e70545.
    PubMed         Abstract available


    Int J Hematol

  8. MIZUTA S, Kobayashi K, Kawata T, Ohashi Y, et al
    Dimensionality reduction enables MRD visualization in single-sample flow cytometric analysis in acute leukemia.
    Int J Hematol. 2026 Aug 17. doi: 10.1007/s12185-026-04268.
    PubMed         Abstract available


    Leuk Lymphoma

  9. VON LUCADOU M, Burbaum LC, Marklin M, Heitmann JS, et al
    Soluble PD-L1 as prognostic biomarker in acute myeloid leukemia.
    Leuk Lymphoma. 2026 Aug 18:1-9. doi: 10.1080/10428194.2026.2707891.
    PubMed         Abstract available

  10. DEANGELO DJ, Chen Y, Cassaday RD, Hibma JE, et al
    Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.
    Leuk Lymphoma. 2026 Aug 18:1-11. doi: 10.1080/10428194.2026.2714343.
    PubMed         Abstract available

  11. UYEMURA B, Hollnagel F, Hall A, Brunner M, et al
    Impact of Area Deprivation Index in patients with newly diagnosed acute myeloid leukemia treated with a venetoclax-based regimen: a single-center retrospective study.
    Leuk Lymphoma. 2026 Aug 16:1-8. doi: 10.1080/10428194.2026.2711591.
    PubMed         Abstract available


    Leukemia

  12. DABKOWSKA A, Janowska M, Pastorczak A, Domka K, et al
    mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.
    Leukemia. 2026 Aug 19. doi: 10.1038/s41375-026-03093.
    PubMed         Abstract available

  13. STAEHLE AM, Perner F, Staehle HF, Gellrich K, et al
    A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia.
    Leukemia. 2026 Aug 19. doi: 10.1038/s41375-026-03095.
    PubMed         Abstract available

  14. ESPARZA N, Defrene J, Bresson E, Soufflet AC, et al
    Modeling KRAS mutations in KMT2A::MLLT3 acute myeloid leukemia promotes leukemic progression and transcriptional rewiring.
    Leukemia. 2026 Aug 18. doi: 10.1038/s41375-026-03112.
    PubMed        


    Oncogene

  15. PANDA S, Wang Y, Dogiparthi VR, Becker M, et al
    The Inv(16) Oncogene CBFB::MYH11 is Required for the Survival of Leukemia Cells in the Blood and Spleen, but not the Bone Marrow.
    Oncogene. 2026 Aug 17. doi: 10.1038/s41388-026-03956.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum